Global Medical REIT (GMRE) Stock Price, News & Analysis

Company Overview

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Key Stats

• Today's Range: $8.53 to $8.67
• 50-Day Range: $8.58 to $10.17
• 52-Week Range: $7.98 to $11.59
• Volume: 322,246 shs
• Average Volume: 365,958 shs
• Market Capitalization: $576.82 million
• P/E Ratio: N/A
• Dividend Yield: 9.73%
• Price Target: $11.25
• Consensus Rating: Buy

Global Medical REIT Stock Analysis - MarketRank™

Global Medical REIT scored higher than 87% of companies evaluated by MarketBeat, and ranked 194th out of 930 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Global Medical REIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Global Medical REIT has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 6.02%

Earnings Growth

Earnings for Global Medical REIT are expected to grow by 6.02% in the coming year, from $0.83 to $0.88 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Global Medical REIT is -431.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Global Medical REIT is -431.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Global Medical REIT has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Global Medical REIT has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.80% of the outstanding shares of Global Medical REIT have been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently decreased by 4.00%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Global Medical REIT is a leading dividend payer. It pays a dividend yield of 9.69%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Global Medical REIT does not have a long track record of dividend growth.

Dividend Sustainability

Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 95.45% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -3.19

Percentage of Shares Shorted

1.80% of the outstanding shares of Global Medical REIT have been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently decreased by 4.00%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: N/A

News Sentiment

Global Medical REIT has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Global Medical REIT this week, compared to 2 articles on an average week.

Search Interest

Only 6 people have searched for GMRE on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

MarketBeat Follows

4 people have added Global Medical REIT to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Global Medical REIT insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.20% of the stock of Global Medical REIT is held by insiders.

Percentage Held by Institutions

57.52% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GMRE Stock Analysis - Frequently Asked Questions

How have GMRE shares performed this year?

Global Medical REIT's stock was trading at $11.10 at the start of the year. Since then, GMRE stock has decreased by 22.2% and is now trading at $8.6350.
View the best growth stocks for 2024 here.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its earnings results on Wednesday, November, 6th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by $0.18. The firm had revenue of $34.26 million for the quarter, compared to analysts' expectations of $34.88 million. Global Medical REIT had a trailing twelve-month return on equity of 0.86% and a net margin of 3.23%.

When did Global Medical REIT IPO?

Global Medical REIT (GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Top institutional investors of Global Medical REIT include State Street Corp (2.88%), Geode Capital Management LLC (2.43%), Stifel Financial Corp (1.41%) and Charles Schwab Investment Management Inc. (1.30%). Insiders that own company stock include Henry Cole and Jeffrey Busch.
View institutional ownership trends.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Medical REIT investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), AUO (AUOTY), The RMR Group (RMR), Waste Connections (WCN), Voyager Therapeutics (VYGR) and Humana (HUM).

Company Calendar

• Ex-Dividend for 10/8 Dividend: 9/20/2024
• Dividend Payable: 10/08/2024
• Last Earnings: 11/06/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/25/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Real estate investment trusts
• Sub-Industry: Trading
• Current Symbol: NYSE:GMRE
• CUSIP: N/A
• CIK: 1533615
• Web: www.globalmedicalreit.com
• Phone: (202) 524-6851
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $11.25
• High Stock Price Target: $12.00
• Low Stock Price Target: $10.00
• Potential Upside/Downside: +30.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 10.40
• P/E Growth: 1.49
• Net Income: $20.61 million
• Net Margins: 3.23%
• Pretax Margin: 3.15%
• Return on Equity: 0.86%
• Return on Assets: 0.35%

Debt

• Debt-to-Equity Ratio: 1.26
• Current Ratio: 0.28
• Quick Ratio: 0.28

Sales & Book Value

• Annual Sales: $141.05 million
• Price / Sales: 4.09
• Cash Flow: $1.25 per share
• Price / Cash Flow: 6.90
• Book Value: $8.10 per share
• Price / Book: 1.07

Miscellaneous

• Outstanding Shares: 66,800,000
• Free Float: 61,325,000
• Market Cap: $576.82 million
• Optionable: Optionable
• Beta: 1.25